Srpt investors have opportunity to lead sarepta therapeutics, inc. securities fraud lawsuit with the schall law firm

Los angeles , june 30, 2025 /prnewswire/ -- the schall law firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against sarepta therapeutics, inc. ("sarepta" or "the company") (nasdaq: srpt) for violations of §§10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between june 22, 2023 and june 24, 2025, inclusive (the "class period"), are encouraged to contact the firm before august 25, 2025.
SRPT Ratings Summary
SRPT Quant Ranking